January is often a time for setting health goals, with weight loss topping many New Year’s resolutions. As people explore the best path forward, they may encounter a variety of ...

New research from CSIRO, Australia's national science agency, has unveiled the power of personalized goal-setting for ...

People are losing much more than fat.

Here’s a look back at the year’s Top 10 stories involving DODEA-Pacific teams and athletes: Kadena’s Tyler Smith boots the ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

Chocolate is beloved by so many people, and the care and attention that goes into making a box of chocolates truly makes it a ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...

It's been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Viking Therapeutics' leading candidate, VK2735, is a potential GLP-1 weight loss medicine. It reported ...

For weight loss drugs like Ozempic and Wegovy, 2024 was a big year. More patients are relying on them to manage their weight, treat diabetes, or prevent heart attacks and strokes. And while they are ...

Figuring out if GLP-1s are the right fit for you isn’t something to tackle alone—and that’s where Mochi Health comes in.